A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With Psoriasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a phase 1, randomized, single‐center, 3‐part, study to assess the safety, tolerability, PK, and PD, of single and multiple doses of CC‐92252 in healthy adult subjects and multiple doses of CC‐92252 in adult subjects with psoriasis.
Epistemonikos ID: d1ec0292ec3ea67f322aa6a49fbcb9fe578f2258
First added on: May 22, 2024